We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+4.98%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+434.06%
AUM
$130B
AUM Growth
+$12.3B
Cap. Flow
+$1.54B
Cap. Flow %
1.18%
Top 10 Hldgs %
17.24%
Holding
8,628
New
1,223
Increased
3,315
Reduced
2,707
Closed
1,164

Top Sells

Rank Stock Value
1
V icon
Visa
V
+$548M
2
MU icon
Micron Technology
MU
+$461M
3
C icon
Citigroup
C
+$334M
4
AVGO icon
Broadcom
AVGO
+$319M
5
ABBV icon
AbbVie
ABBV
+$267M

Sector Composition

Rank Sector Weight
1 Technology 6.99%
2 Financials 5.48%
3 Industrials 4.89%
4 Consumer Discretionary 4.88%
5 Healthcare 4.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TENX icon
7126
Tenax Therapeutics
TENX
$498M
$30K ﹤0.01%
3
+2
+200% +$29.7K
LGCY
7127
PUT
DELISTED
Legacy Reserves Inc. Common Stock
LGCY
$30K ﹤0.01%
19,900
-9,400
-32% -$12.2K
IPCI
7128
CALL
DELISTED
Intellipharmaceuticals International Inc.
IPCI
$30K ﹤0.01%
3,060
+1,090
+55% +$15.6K
BDSI
7129
CALL
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$30K ﹤0.01%
10,200
-6,800
-40% -$20.7K
VVUS
7130
PUT
DELISTED
Vivus Inc
VVUS
$30K ﹤0.01%
3,020
+1,460
+94% +$15.4K
RCKT icon
7131
Rocket Pharmaceuticals
RCKT
$387M
$29K ﹤0.01%
4,048
-108
-3% -$494
JRJC
7132
CALL
DELISTED
China Finance Online Co., Ltd.
JRJC
$29K ﹤0.01%
+1,370
New +$26.3K
IDXG
7133
DELISTED
Interpace Biosciences, Inc. Common Stock
IDXG
$29K ﹤0.01%
+1,885
New +$22.3K
SHOS
7134
PUT
DELISTED
Sears Hometown and Outlet Stores, Inc.
SHOS
$29K ﹤0.01%
+11,400
New +$24.8K
CBK
7135
DELISTED
Christopher & Banks Corporation
CBK
$29K ﹤0.01%
21,343
+4,817
+29% +$6.66K
CXRX
7136
CALL
DELISTED
Concordia International Corp. Common Stock
CXRX
$29K ﹤0.01%
24,300
-1,500
-6% -$2.05K
CGNT
7137
DELISTED
Cogentix Medical, Inc.
CGNT
$29K ﹤0.01%
+11,197
New +$24.5K
KGJI
7138
DELISTED
Kingold Jewelry Inc.
KGJI
$29K ﹤0.01%
+2,332
New +$24K
ETRM
7139
DELISTED
EnteroMedics Inc.
ETRM
$29K ﹤0.01%
+16,421
New +$48.4K
CCLD icon
7140
CareCloud
CCLD
$98.6M
$28K ﹤0.01%
+18,922
New +$26.4K
KUST
7141
Kustom Entertainment Inc
KUST
$802K
0
SES
7142
DELISTED
Synthesis Energy Systems Inc.
SES
$28K ﹤0.01%
+818
New +$23.7K
GLBR
7143
DELISTED
Global Brokerage, Inc. Class A Common Stock
GLBR
$28K ﹤0.01%
16,399
-12,624
-43% -$21K
CPHI icon
7144
China Pharma Holdings
CPHI
$49M
$27K ﹤0.01%
312
+246
+373% +$24.4K
DXLG icon
7145
Destination XL Group
DXLG
$32.6M
$27K ﹤0.01%
14,202
+3,563
+33% +$6.81K
NOTV
7146
DELISTED
Inotiv
NOTV
$27K ﹤0.01%
15,599
+664
+4% +$1.14K
OBE
7147
PUT
Obsidian Energy
OBE
$640M
$27K ﹤0.01%
3,714
-1,157
-24% -$8.57K
REPX icon
7148
Riley Exploration Permian
REPX
$755M
$27K ﹤0.01%
+3,333
New +$26.6K
KSPN
7149
DELISTED
Kaspien Holdings Inc. Common Stock
KSPN
$27K ﹤0.01%
680
+139
+26% +$5.13K
AT
7150
PUT
DELISTED
Atlantic Power Corporation
AT
$27K ﹤0.01%
+11,100
New +$26.7K

Similar funds

Citadel Advisors's Q3 2017 Portfolio in Review

As of Q3 2017, Citadel Advisors held 8,628 positions worth $130B, up 10% from $118B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Citadel Advisors's Q3 2017 filing shows 1,223 new, 3,315 increased, 2,707 reduced and 1,164 closed positions. Its largest new stake was Goldman Sachs: 2,394,331 shares worth $568M. The largest sale was Visa, an estimated $548M.

By sector, the portfolio is most concentrated in Technology at 7% of assets, down from 7.1% a quarter earlier, followed by Financials and Industrials.

  • Citadel Advisors's largest Q3 2017 buy was Goldman Sachs: 2,394,331 shares worth $568M.
  • Citadel Advisors added most to Citizens Financial Group in Q3 2017, an estimated $304M increase.
  • Citadel Advisors's biggest Q3 2017 reduction was Visa, cutting an estimated $548M.
  • Citadel Advisors fully exited Citigroup in Q3 2017, selling an estimated $334M.
  • Citadel Advisors's ten largest holdings make up 17% of its $130B portfolio in Q3 2017.
  • Citadel Advisors opened 1,223 new positions and closed 1,164 in Q3 2017.
  • Citadel Advisors's portfolio value rose 10% quarter-over-quarter to $130B.

Based on Citadel Advisors's 13F filing for Q3 2017, filed 9 Nov 2017.